Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia

NCT02688140 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: Arsenic trioxide
DRUG: Idarubicin
DRUG: Cytarabine
DRUG: Tretinoin
DRUG: Mitoxantrone
DRUG: Mercaptopurine
DRUG: Methotrexate

Sponsor

Technische Universität Dresden

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]